SCHEMBL99080

SCHEMBL99080

CCC(C)c1cc(C(C)c2cc(C(C)CC)cc(C(C)(C)C)c2O)c(O)c(C(C)(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.47
CYP2C19 P33261 5/20 0.47
CYP1A2 P05177 4/20 0.47
TSHR P16473 4/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.42
RORC P51449 1/20 0.39
CA2 P00918 3/20 0.38
CA1 P00915 2/20 0.38
ALDH1A1 P00352 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
POLB P06746 1/20 0.37
TYR P14679 1/20 0.37
ALOX15 P16050 4/20 0.37
GAA P10253 2/20 0.37
HSPA5 P11021 2/20 0.37
USP2 O75604 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL144821 0.88 CA2 (0.50) CYP2C9CYP2C19CYP1A2TSHRCYP3A4
SCHEMBL14279821 0.83 GAA (0.46) CYP2C9CYP2C19CYP1A2TSHRCYP3A4
SCHEMBL2951999 0.83 CYP1A2 (0.44) CYP2C9CYP2C19CYP1A2TSHRCYP3A4
SCHEMBL809764 0.82 CYP1A2 (0.54) CYP2C9CYP2C19CYP1A2TSHRCYP3A4
SCHEMBL12626206 0.81 CYP2C9 (0.52) CYP2C9CYP2C19CYP1A2TSHRCYP3A4
SCHEMBL6744605 0.80 TSHR (0.44) CYP2C9TSHRRORCCA2CA1
SCHEMBL10778785 0.80 HSPA5 (0.56) CYP2C9CYP2C19CYP1A2TSHRCYP3A4
SCHEMBL30337273 0.80 HSPA5 (0.56) CYP2C9CYP2C19CYP1A2TSHRCYP3A4
SCHEMBL22190072 0.80 CYP1A2 (0.53) CYP2C9CYP2C19CYP1A2TSHRCYP3A4
Propofol SCHEMBL4048377 0.78 TSHR (0.50) CYP2C9CYP2C19CYP1A2TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 526 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024049033-A1 ISOCYANATE COMPOSITION 한화솔루션 주식회사 2024-03-07 WO claimed
US-20220306835-A1 METHOD FOR PREPARING POLYISOCYANATE COMPOSITION Hanwha Solutions Corporation (KR) 2022-09-29 US claimed
EP-4019564-A1 METHOD FOR PRODUCING POLYISOCYANATE COMPOSITION Hanwha Solutions Corporation (KR) 2022-06-29 EP claimed
US-9133121-B2 Weakly basic hindered amines compounds having carbonate skeletons, synthetic resin compositions and coating compositions NEGISHI YOSHINORI (JP) 2015-09-15 US claimed
US-5112891-A Cyclic Phosphite Heat Stabilizer ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1992-05-12 US claimed
US-5081170-A Polyolefin, phenolic antioxidant, light stabilizer, sulfur antioxidant, talc filler, weatherproofing ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1992-01-14 US claimed
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof ADEKA CORPORATION (JP) 2026-05-12 US disclosed
EP-4726011-A1 FLAME RETARDANT, COMPOSITION, AND MOLDED ARTICLE ADEKA CORPORATION (JP) 2026-04-15 EP disclosed
US-20260092163-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION, AND MOLDED PRODUCT ADEKA CORPORATION (JP) 2026-04-02 US disclosed
US-12565572-B2 Method for preparing polyisocyanate composition Hanwha Solutions Corporation (KR) 2026-03-03 US disclosed
US-12540122-B2 Nucleating agent, synthetic-resin composition containing same, and molded object thereof ADEKA CORPORATION (JP) 2026-02-03 US disclosed
US-12540229-B2 Flame-retardant composition and flame-retardant synthetic resin composition ADEKA CORPORATION (JP) 2026-02-03 US disclosed
US-20260022204-A1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION CONTAINING SAME, ANTISTATIC RESIN COMPOSITION CONTAINING SAID ANTISTATIC AGENT OR SAID ANTISTATIC AGENT COMPOSITION, AND MOLDED BODY AND FILM THEREOF ADEKA CORPORATION (JP) 2026-01-22 US disclosed
US-4885326-A 2,2'-ALKYLIDENE-BISPHENOL CYCLIC ALKYLPHOSPHITE AND 3,5-DIALKYL-4-HYDROXYPHENYLPROPIONIC ACID ESTER; HEAT, LIGHT, AND OXIDATION RESISTANCE ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1989-12-05 US disclosed
EP-0336606-A1 Composition of stabilized synthetic resin ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1989-10-11 EP disclosed
US-4871793-A Polyphenylene sulfide resin compositions having improved resistance to deterioration when exposed to light and containing alkylidene bis (benzotriazolylphenols) NAKAHARA YUTAKA (JP) 1989-10-03 US disclosed
US-4812498-A Polycarbonate resin compositions having improved resistance to deterioration when exposed to light and containing alkylidene bis(benzotriazolyl phenols) ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1989-03-14 US disclosed
EP-0257321-A2 Improving weatherability and adherence of polypropylene ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1988-03-02 EP disclosed
US-4684679-A DISCOLORATION INHIBITION ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1987-08-04 US disclosed
EP-0188236-A2 Polyacetal resin compositions having improved resistance to deterioration when exposed to light and containing alkylidene bis(benzotriazolyl phenols) ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1986-07-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12540122-B2 Nucleating agent, synthetic-resin composition containing same, and molded object thereof NXF1, NAP1L1, POT1 CYP2C9 4882/4885CYP2C19 4857/4885CYP1A2 4266/4885
US-12565572-B2 Method for preparing polyisocyanate composition TYR, TDO2, ALKBH3 CYP2C9 158/4885CYP2C19 866/4885CYP1A2 90/4885
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof SORD, SUCLA2, SUCLG1 CYP2C9 3461/4885CYP2C19 4010/4885CYP1A2 2298/4885
US-20260022204-A1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION CONTAINING SAME, ANTISTATIC RESIN COMPOSITION CONTAINING SAID ANTISTATIC AGENT OR SAID ANTISTATIC AGENT COMPOSITION, AND MOLDED BODY AND FILM THEREOF PHOSPHO1, EBP, CA1 CYP2C9 3250/4885CYP2C19 3433/4885CYP1A2 1736/4885
US-12540229-B2 Flame-retardant composition and flame-retardant synthetic resin composition PAF1, RER1, POLR2A CYP2C9 4058/4885CYP2C19 4016/4885CYP1A2 2569/4885
US-20260092163-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION, AND MOLDED PRODUCT PHOSPHO1, PAF1, PPA1 CYP2C9 4704/4885CYP2C19 4702/4885CYP1A2 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.